医学
2019年冠状病毒病(COVID-19)
严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)
2019-20冠状病毒爆发
利托那韦
冠状病毒
倍他科诺病毒
大流行
重症监护医学
冠状病毒感染
肺炎
病毒学
内科学
疾病
传染病(医学专业)
爆发
病毒
病毒载量
抗逆转录病毒疗法
作者
Swapnil Hiremath,Michaeline McGuinty,Christos Argyropoulos,K. Scott Brimble,Pierre Brown,Zain Chagla,Rebecca Cooper,Stephanie Hoar,David Juurlink,Darin Treleaven,Michael Walsh,Angie Yeung,Peter Blake
出处
期刊:Clinical Journal of The American Society of Nephrology
[American Society of Nephrology]
日期:2022-06-09
卷期号:17 (8): 1247-1250
被引量:7
摘要
As of December 2021, 18.2 million have died globally from coronavirus disease 2019 (COVID-19) due to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and millions more suffer from longer-term consequences ([1][1]). Morbidity and mortality from COVID-19 is higher in patients who are
科研通智能强力驱动
Strongly Powered by AbleSci AI